Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice

Individuals surviving cancer and brain tumors may experience growth hormone (GH) deficiency as a result of tumor growth, surgical resection and/or radiotherapy involving the hypothalamic-pituitary region. Given the pro-mitogenic and anti-apoptotic properties of GH and insulin-like growth factor-I, t...

Descripción completa

Detalles Bibliográficos
Autores principales: Boguszewski, Margaret C. S., Cardoso-Demartini, Adriane A., Boguszewski, Cesar Luiz, Chemaitilly, Wassim, Higham, Claire E., Johannsson, Gudmundur, Yuen, Kevin C. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416866/
https://www.ncbi.nlm.nih.gov/pubmed/34304361
http://dx.doi.org/10.1007/s11102-021-01173-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8416866/
https://www.ncbi.nlm.nih.gov/pubmed/34304361
http://dx.doi.org/10.1007/s11102-021-01173-0

Ejemplares similares